For Patients With Fatty Liver: Time to Make a Deal at HealthBulance.

Health care is our expertise. As experimental drugs to treat non-alcoholic steatohepatitis (NASH) continue to dash themselves on the shoals of the federal regulatory system, clinicians should know that at least one effective therapy exists.

Medscape

For Patients With Fatty Liver: Time to Make a Deal

For Patients With Fatty Liver: Time to Make a Deal

As experimental drugs to treat non-alcoholic steatohepatitis (NASH) continue to dash themselves on the shoals of the federal regulatory system, clinicians should know that at least one effective therapy exists.